fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

EU drug watchdog warns of fake Ozempic pens

Written by | 22 Oct 2023

The European Medicines Agency (EMA) is warning patients and healthcare professionals to beware of pre-filled pens falsely labelled as Ozempic, a diabetes medicine linked to weight loss. National… read more.

Semaglutide (Ozempic/Wegovy) shows 3-year efficacy for blood sugar control and weight loss

Written by | 5 Oct 2023

Data from a “real world” study indicates that treatment with the semaglutide (Ozempic/Wegovy) for type 2 diabetes significantly improves both blood sugar control and weight loss for up… read more.

NHS England moves to restrict use of GLP-1 agonists

Written by | 10 Jul 2023

On 27th June 2023 NHS England issued a Medicine Supply Notification (MSN/2023/061) concerning GLP-1 receptor agonists (GLP-1 RAs) used for management of type 2 diabetes. This action has… read more.

Pharmacy-led obesity management with GLP agonists

Written by | 21 Jun 2023

Deborah Evans is Superintendent Pharmacist and Clinic Director at Remedi Health, where she runs a weight management service, including the provision of semaglutide. In this series of short… read more.

Offering the best weight-loss service for patients

Written by | 20 Jun 2023

People seeking semaglutide for weight management from a pharmacy-led service need to feel assured that the service is ethical and legal and has the best interests of the… read more.

How to provide semaglutide for ethical weight-loss

Written by | 19 Jun 2023

Taking time to understand a patient’s weight loss goals and checking their medical history to ensure there are no underlying problems that may need onward referral are both… read more.

Semaglutide: what you need to know about online supply and effective use

Written by | 18 Jun 2023

Online supply of semaglutide makes the medicine more accessible but may not provide the best support or guidance to enable people to get the best out of the… read more.

Wegovy or Ozempic – does it matter?

Written by | 17 Jun 2023

Wegovy and Ozempic both contain semaglutide but are authorised for different indications. They are also presented in slightly different concentrations and dose schedules, explains Deborah Evans, Superintendent Pharmacist… read more.

Semaglutide and how it makes you want to eat less

Written by | 16 Jun 2023

Deborah Evans is superintendent pharmacist and clinic director at Remedi Health, an independent pharmacy and healthcare clinic in Winchester. Remedi Health runs a weight management service and has… read more.

Investigational 2.0 mg dose of once weekly Ozempic demonstrates superior reductions in blood sugar vs Ozempic 1.0 mg in type II diabetes – Novo Nordisk

Written by | 4 Jul 2021

Novo Nordisk presented data showing that an investigational 2.0 mg dose of Ozempic (semaglutide) provided statistically significant and superior reductions in blood sugar (HbA1C) compared with Ozempic 1.0… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.